Medtronic PLC (LTS:0Y6X)
$ 81.63 1.13 (1.41%) Market Cap: 104.56 Bil Enterprise Value: 125.12 Bil PE Ratio: 25.24 PB Ratio: 2.18 GF Score: 78/100

Medtronic PLC at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2021 / 05:10PM GMT
Release Date Price: $118.65 (+0.03%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Hi, everyone. I'm Steve Lichtman, medical device analyst at Oppenheimer. I apologize for the slight technical delay. Welcome to the 31st Annual Oppenheimer Healthcare Conference. Very happy to have with us up next, Medtronic. With us today is Sean Salmon. Sean, I think you win the award for longest title of the day, Executive Vice President, and President, Diabetes, and President, Cardiovascular Portfolio. So needless to say, we've got a lot of topics that we can hit today. So thanks for joining us, Sean. And if you have any questions, for those dialed in, please keep them in, and I'll make sure to get them right over to Sean.

Questions & Answers

Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

So first, I thought we would start, Sean, with diabetes. Maybe start at a high level from a market perspective. What do you believe has been the biggest headwind to type 1 adoption historically? And what do you see as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot